UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Discovery of 1-(3‘-Aminobenzisoxazol-5‘-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2‘-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide Hydrochloride (Razaxaban), a Highly Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor

Journal of medicinal chemistry, 2005-03, Vol.48 (6), p.1729-1744

2005

Volltextzugriff (PDF)

The discovery and SAR of cyclopenta[b]furans as inhibitors of CCR2

Bioorganic & medicinal chemistry letters, 2014-05, Vol.24 (9), p.2137-2140

2014

Volltextzugriff (PDF)

Practical Synthesis of Ethyl 3‑Fluoro-1-pyrrole-2-carboxylate: A Key Fragment of a Potent Drug Candidate against Hepatitis B Virus

Organic process research & development, 2020-05, Vol.24 (5), p.792-801

2020

Volltextzugriff (PDF)

6‑Benzhydryl-4-amino-quinolin-2-ones as Potent Cannabinoid Type 1 (CB1) Receptor Inverse Agonists and Chemical Modifications for Peripheral Selectivity

Journal of medicinal chemistry, 2018-11, Vol.61 (22), p.10276-10298

2018

Volltextzugriff (PDF)

Synthesis of substituted 2,4,5,6-tetrahydrocyclopenta[c]pyrazoles and 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles by intramolecular nitrilimine cycloaddition

Tetrahedron letters, 2014-03, Vol.55 (13), p.2150-2153

2014

Volltextzugriff (PDF)

Efficient Synthesis of 5-(Bromomethyl)- and 5-(Aminomethyl)-1-THP-Indazole

Journal of organic chemistry, 1997-08, Vol.62 (16), p.5627-5629

1997

Volltextzugriff (PDF)

Lab-Scale Preparation of a Novel Cyclopenta[b]furan Chemokine Receptor Antagonist

Organic process research & development, 2014-12, Vol.18 (12), p.1630-1640

2014

Volltextzugriff (PDF)

Lab-Scale Preparation of a Novel Carbocyclic Chemokine Receptor Antagonist

Organic process research & development, 2014-12, Vol.18 (12), p.1622-1629

2014

Volltextzugriff (PDF)

Synthesis of Mavatrep: A Potent Antagonist of Transient Receptor Potential Vanilloid‑1

Organic process research & development, 2015-11, Vol.19 (11), p.1774-1783

2015

Volltextzugriff (PDF)

Regulated Expression of the Escherichia coli lepB Gene as a Tool for Cellular Testing of Antimicrobial Compounds That Inhibit Signal Peptidase I In Vitro

Antimicrobial Agents and Chemotherapy, 2002-11, Vol.46 (11), p.3549-3554

2002

Volltextzugriff (PDF)

Structure-Based Design of Novel Guanidine/Benzamidine Mimics: Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants

Journal of medicinal chemistry, 2003-10, Vol.46 (21), p.4405-4418

2003

Volltextzugriff (PDF)

Suzuki−Miyaura Approach to JNJ-26076713, an Orally Active Tetrahydroquinoline-Containing αVβ3/αVβ5 Integrin Antagonist. Enantioselective Synthesis and Stereochemical Studies

Journal of organic chemistry, 2008-03, Vol.73 (6), p.2302-2310

2008

Volltextzugriff (PDF)

Design, Synthesis, and Structure−Activity Relationships of Macrocyclic Hydroxamic Acids That Inhibit Tumor Necrosis Factor α Release in Vitro and in Vivo

Journal of medicinal chemistry, 2001-08, Vol.44 (16), p.2636-2660

2001

Volltextzugriff (PDF)

Isolation and synthesis of 2-chloro-10-α-hydroxynaltrexone, a new naltrexone degradant

Tetrahedron letters, 2003-09, Vol.44 (39), p.7381-7384

2003

Volltextzugriff (PDF)

2-Fluoro-4-pyridinylmethyl Analogues of Linopirdine as Orally Active Acetylcholine Release-Enhancing Agents with Good Efficacy and Duration of Action

Journal of medicinal chemistry, 1998-11, Vol.41 (23), p.4615-4622

1998

Volltextzugriff (PDF)

Imidazo[4,5- b]pyridines as corticotropin releasing factor receptor ligands

Bioorganic & medicinal chemistry letters, 2003-01, Vol.13 (1), p.125-128

2003

Volltextzugriff (PDF)

Boat/chair topographic stereoselection during anionic oxy-Cope rearrangement of 1-alkenyl-2-cyclopentenyl-endo-norbornan-2-ols

Journal of the American Chemical Society, 1990, Vol.112 (1), p.265-277

1990

Volltextzugriff (PDF)

Chiral aminocyclopentene-based cycloaddition strategies to bicyclic [3.3.0] rings

Tetrahedron: asymmetry, 2013-06, Vol.24 (11), p.651-656

2013

Volltextzugriff (PDF)

Synthesis of N-Butyl Side Chain Hydroxylated Metabolites of Roxifiban, a Platelet Glycoprotein IIb/IIIa Receptor Antagonist

Heterocycles, 2004-07, Vol.63 (7), p.1585

2004

Volltextzugriff (PDF)

ChemInform Abstract: Synthesis of Substituted 2,4,5,6-Tetrahydrocyclopenta[c]pyrazoles and 2,4,5,6-Tetrahydropyrrolo[3,4-c]pyrazoles by Intramolecular Nitrilimine Cycloaddition

ChemInform, 2014-09, Vol.45 (35), p.no-no

2014

Volltextzugriff (PDF)

Application of Modified Flavone Closure for the Preparation of Racemic L86-8275

Organic process research & development, 1999-07, Vol.3 (4), p.256-259

1999

Volltextzugriff (PDF)

MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products

Bioorganic & medicinal chemistry letters, 1998-10, Vol.8 (20), p.2839-2844

1998

Volltextzugriff (PDF)

Efficient, enantioselective synthesis of a β,β-disubstituted carboxylic acid by Ru-XylPhanePhos-catalyzed asymmetric hydrogenation

Tetrahedron letters, 2008-09, Vol.49 (36), p.5328-5331

2008

Volltextzugriff (PDF)

Patent Update: Agents Indicated for the Treatment of Alzheimer's Disease: Recent Advances in Patents from July to December, 1992

Expert opinion on therapeutic patents, 1993-02, Vol.3 (2), p.293-305

Teleha, Christopher A

1993

Volltextzugriff (PDF)

Synthesis of an αvβ3 integrin antagonist intermediate via asymmetric hydrogenation of an α,β-unsaturated ester with BoPhoz-iridium and BoPhoz-rhodium catalysts

Tetrahedron: asymmetry, 2008-05, Vol.19 (8), p.938-944

2008

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(46)
Dissertationen
(1)

Sprache

Englisch
(47)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Discovery of 1-(3‘-Aminobenzisoxazol-5‘-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2‘-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide Hydrochloride (Razaxaban), a Highly Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor

The discovery and SAR of cyclopenta[b]furans as inhibitors of CCR2

Practical Synthesis of Ethyl 3‑Fluoro-1-pyrrole-2-carboxylate: A Key Fragment of a Potent Drug Candidate against Hepatitis B Virus

6‑Benzhydryl-4-amino-quinolin-2-ones as Potent Cannabinoid Type 1 (CB1) Receptor Inverse Agonists and Chemical Modifications for Peripheral Selectivity

Synthesis of substituted 2,4,5,6-tetrahydrocyclopenta[c]pyrazoles and 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles by intramolecular nitrilimine cycloaddition

Efficient Synthesis of 5-(Bromomethyl)- and 5-(Aminomethyl)-1-THP-Indazole

Lab-Scale Preparation of a Novel Cyclopenta[b]furan Chemokine Receptor Antagonist

Lab-Scale Preparation of a Novel Carbocyclic Chemokine Receptor Antagonist

Synthesis of Mavatrep: A Potent Antagonist of Transient Receptor Potential Vanilloid‑1

Regulated Expression of the Escherichia coli lepB Gene as a Tool for Cellular Testing of Antimicrobial Compounds That Inhibit Signal Peptidase I In Vitro

Structure-Based Design of Novel Guanidine/Benzamidine Mimics: Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants

Suzuki−Miyaura Approach to JNJ-26076713, an Orally Active Tetrahydroquinoline-Containing αVβ3/αVβ5 Integrin Antagonist. Enantioselective Synthesis and Stereochemical Studies

Design, Synthesis, and Structure−Activity Relationships of Macrocyclic Hydroxamic Acids That Inhibit Tumor Necrosis Factor α Release in Vitro and in Vivo

Isolation and synthesis of 2-chloro-10-α-hydroxynaltrexone, a new naltrexone degradant

2-Fluoro-4-pyridinylmethyl Analogues of Linopirdine as Orally Active Acetylcholine Release-Enhancing Agents with Good Efficacy and Duration of Action

Imidazo[4,5- b]pyridines as corticotropin releasing factor receptor ligands

Boat/chair topographic stereoselection during anionic oxy-Cope rearrangement of 1-alkenyl-2-cyclopentenyl-endo-norbornan-2-ols

Chiral aminocyclopentene-based cycloaddition strategies to bicyclic [3.3.0] rings

Synthesis of N-Butyl Side Chain Hydroxylated Metabolites of Roxifiban, a Platelet Glycoprotein IIb/IIIa Receptor Antagonist

ChemInform Abstract: Synthesis of Substituted 2,4,5,6-Tetrahydrocyclopenta[c]pyrazoles and 2,4,5,6-Tetrahydropyrrolo[3,4-c]pyrazoles by Intramolecular Nitrilimine Cycloaddition

Application of Modified Flavone Closure for the Preparation of Racemic L86-8275

MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products

Efficient, enantioselective synthesis of a β,β-disubstituted carboxylic acid by Ru-XylPhanePhos-catalyzed asymmetric hydrogenation

Patent Update: Agents Indicated for the Treatment of Alzheimer's Disease: Recent Advances in Patents from July to December, 1992

Synthesis of an αvβ3 integrin antagonist intermediate via asymmetric hydrogenation of an α,β-unsaturated ester with BoPhoz-iridium and BoPhoz-rhodium catalysts

Suchergebnisse filtern